MXPA04003212A - Modelo in vitro para actividad priocida. - Google Patents

Modelo in vitro para actividad priocida.

Info

Publication number
MXPA04003212A
MXPA04003212A MXPA04003212A MXPA04003212A MXPA04003212A MX PA04003212 A MXPA04003212 A MX PA04003212A MX PA04003212 A MXPA04003212 A MX PA04003212A MX PA04003212 A MXPA04003212 A MX PA04003212A MX PA04003212 A MXPA04003212 A MX PA04003212A
Authority
MX
Mexico
Prior art keywords
model
bas
prions
proteinaceous material
vitro model
Prior art date
Application number
MXPA04003212A
Other languages
English (en)
Inventor
E Mcdonnell Gerarld
Original Assignee
Steris Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steris Inc filed Critical Steris Inc
Publication of MXPA04003212A publication Critical patent/MXPA04003212A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A61L2/186—Peroxide solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/14—Plasma, i.e. ionised gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/20—Gaseous substances, e.g. vapours
    • A61L2/208—Hydrogen peroxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/26—Accessories or devices or components used for biocidal treatment
    • A61L2/28—Devices for testing the effectiveness or completeness of sterilisation, e.g. indicators which change colour
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/39—Organic or inorganic per-compounds
    • C11D3/3947—Liquid compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/10—Apparatus features
    • A61L2202/17—Combination with washing or cleaning means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20—Targets to be treated
    • A61L2202/24—Medical instruments, e.g. endoscopes, catheters, sharps
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D2111/00—Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
    • C11D2111/10—Objects to be cleaned
    • C11D2111/14—Hard surfaces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plasma & Fusion (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se ha encontrado un material proteinaceo que muestra actividad y respuesta al tratamiento semejantes a los de los priones causantes de enfermedades., como el CID. Un modelo de prion que incorpora el material proteinaceo tiene diversas aplicaciones. El modelo tiene la propiedad de ser cultivado in vivo o in vitro, permitiendo el escrutinio rapido de farmacos potenciales para tratar animales o humanos, o los metodo de tratamiento de productos alimenticios o los articulos que puedan entrar en contacto con los priones, como los dispositivos medicos o dentales. Con el uso del modelo se han desarrollado diversos metodos y materiales de tratamiento.
MXPA04003212A 2001-10-05 2004-04-05 Modelo in vitro para actividad priocida. MXPA04003212A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32746001P 2001-10-05 2001-10-05

Publications (1)

Publication Number Publication Date
MXPA04003212A true MXPA04003212A (es) 2004-07-23

Family

ID=23276633

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04003212A MXPA04003212A (es) 2001-10-05 2004-04-05 Modelo in vitro para actividad priocida.

Country Status (11)

Country Link
US (2) US7129080B2 (es)
EP (1) EP1432993B1 (es)
JP (2) JP2005528883A (es)
CN (1) CN1639575A (es)
AT (1) ATE554755T1 (es)
AU (1) AU2002348517B2 (es)
BR (1) BR0213121A (es)
CA (3) CA2812761C (es)
ES (1) ES2387781T3 (es)
MX (1) MXPA04003212A (es)
WO (1) WO2003031987A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2812761C (en) * 2001-10-05 2018-03-20 Steris Inc. In vitro model for priocidal activity
GB0214007D0 (en) * 2002-06-18 2002-07-31 Common Services Agency Removal of prion infectivity
US7071152B2 (en) * 2003-05-30 2006-07-04 Steris Inc. Cleaning and decontamination formula for surfaces contaminated with prion-infected material
US7470655B2 (en) * 2004-08-06 2008-12-30 Ecolab Inc. Method of inactivating prions
US20060228801A1 (en) * 2005-03-30 2006-10-12 Ben Fryer Integator system and method for rapidly determining effectiveness of a germicidal treatment
US9034390B2 (en) * 2006-05-02 2015-05-19 Bioneutral Laboratories Corporation Anti-microbial composition and method for making and using same
US20090074881A1 (en) * 2006-05-02 2009-03-19 Bioneutral Laboratories Corporation Usa Antimicrobial cidality formulations with residual efficacy, uses thereof, and the preparation thereof
US7922970B2 (en) * 2007-04-03 2011-04-12 Kimberly-Clark Worldwide, Inc. Use of sonication to eliminate prions
US8293174B2 (en) 2007-10-17 2012-10-23 American Sterilizer Company Prion deactivating composition and methods of using same
CN103710256B (zh) * 2013-12-27 2015-03-25 重庆医科大学附属口腔医院 一种根管-根尖周复合体体外模型
US10513678B2 (en) 2015-12-17 2019-12-24 Mesa Laboratories, Inc. Self-contained biological indicator

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941696A (en) 1973-12-20 1976-03-02 Baylor College Of Medicine Sterilization of holding tanks and toilet bowls by quaternary compounds
US4169123A (en) 1975-12-11 1979-09-25 Moore-Perk Corporation Hydrogen peroxide vapor sterilization method
DE2819284C2 (de) * 1977-05-31 1985-12-19 Röhm GmbH, 6100 Darmstadt Künstlicher Stuhl zu diagnostischen Zwecken
US4473550A (en) 1981-01-16 1984-09-25 Rosenbaum Robert S Bactericidal compositions and methods
US5116575A (en) 1986-02-06 1992-05-26 Steris Corporation Powdered anti-microbial composition
US4973449A (en) 1986-03-10 1990-11-27 Mdt Corporation Sterilization method
US5580530A (en) 1987-07-30 1996-12-03 Johnson & Johnson Medical, Inc. Device for vapor sterilization of articles having lumens
US5173259A (en) 1988-04-27 1992-12-22 Tetra Dev-Co Sterilization method for a packing machine that uses liquid disinfectant
US5258162A (en) 1989-11-07 1993-11-02 Tetra Alfa Holdings S.A. Method of producing a gaseous hydrogen peroxide-containing sterilization fluid
US5007232A (en) 1989-11-20 1991-04-16 Abbott Laboratories Apparatus and method of use of sterilizing containers using hydrogen peroxide vapor
GB9022268D0 (en) 1990-10-13 1990-11-28 Cmb Foodcan Plc Sterilising apparatus
US5145642A (en) 1991-01-31 1992-09-08 Mdt Corporation Load compensated water fill for a table top sterilizer
US6395506B1 (en) * 1991-04-18 2002-05-28 Becton, Dickinson And Company Device for monitoring cells
US5260021A (en) 1992-06-29 1993-11-09 Allergan, Inc. Hydrogen peroxide-containing gels and contact lens disinfecting using same
WO1994011034A1 (en) 1992-11-12 1994-05-26 American Sterilizer Company A method of decontaminating freeze dryers
GB9306806D0 (en) 1993-04-01 1993-05-26 Unilever Plc Disinfectant compositions
US5567444A (en) 1993-08-30 1996-10-22 Ecolab Inc. Potentiated aqueous ozone cleaning and sanitizing composition for removal of a contaminating soil from a surface
US5674450A (en) 1994-04-28 1997-10-07 Johnson & Johnson Medical, Inc. Vapor sterilization using a non-aqueous source of hydrogen peroxide
US5756678A (en) 1995-05-01 1998-05-26 Cohesion Technologies, Inc. Prion inactivation in connective tissue materials
US5634880A (en) 1995-05-22 1997-06-03 Johnson & Johnson Medical, Inc. Endoscope pressure equalization system and method
US5600142A (en) 1995-05-26 1997-02-04 Uop Measurement of vaporized hydrogen peroxide
US6010994A (en) 1995-06-07 2000-01-04 The Clorox Company Liquid compositions containing N-alkyl ammonium acetonitrile salts
US6094523A (en) 1995-06-07 2000-07-25 American Sterilizer Company Integral flash steam generator
US5872359A (en) 1995-07-27 1999-02-16 American Sterilizer Company Real-time monitor and control system and method for hydrogen peroxide vapor decontamination
US5848515A (en) 1995-08-11 1998-12-15 Rossi & Catelli S.P.A. Continuous-cycle sterile bottling plant
GB9523717D0 (en) 1995-11-20 1996-01-24 Mdh Ltd Method and apparatus for hydrogen peroxide vapour sterilization
US5788925A (en) 1996-02-16 1998-08-04 Steris Corporation Method for real time monitoring and control of load sterilization and parametric release
US5876664A (en) 1996-06-14 1999-03-02 American Sterilizer Company Continuous-operation, closed loop decontamination system and method
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
WO1998015297A1 (en) 1996-10-09 1998-04-16 Lifetech Corporation Method for the sterilization of biological materials
FR2759589B1 (fr) 1997-02-19 1999-04-23 Colette Balanca Unite automatisee pour l'inactivation du prion et la desinfection de l'instrumentation medico-chirurgicale et dentaire, recuperation et evacuation des produits toxiques et mise en oeuvre
US6322802B1 (en) 1999-06-01 2001-11-27 The Regents Of The University Of California Method of sterilizing
US6719988B2 (en) * 1997-02-21 2004-04-13 The Regents Of The University Of California Antiseptic compositions for inactivating prions
US5779973A (en) 1997-04-01 1998-07-14 Steris Corporation Vapor phase interstitial microbial decontamination of overwrapped IV bags
US5792435A (en) 1997-04-08 1998-08-11 Steris Corporation Vapor phase decontaminant isolator apparatus with integral vapor phase decontaminant generator system
US6162055A (en) 1998-02-13 2000-12-19 Britesmile, Inc. Light activated tooth whitening composition and method of using same
AU6416999A (en) 1998-10-08 2000-04-26 Hampar L. Karagoezian Synergistic antimicrobial, dermatological and ophthalmic preparations containingchlorite and hydrogen peroxide
US6448062B1 (en) 1998-10-30 2002-09-10 Metrex Research Corporation Simultaneous cleaning and decontaminating compositions and methods
FR2792500B1 (fr) 1999-04-23 2004-05-21 Internat Redox Dev Composition aqueuse, notamment sous forme de gel, a base de ho2f , acides et ions metalliques, procede de preparation notamment quand lesdits ions sont ag2+ et utilisation dans le domaine de la desinfection et/ou du traitement de surface
WO2000071575A1 (en) * 1999-05-26 2000-11-30 The Regents Of The University Of California Models of prion disease
IL146769A0 (en) * 1999-06-01 2002-07-25 Univ California Method of sterilizing
WO2001000235A1 (en) 1999-06-29 2001-01-04 Mcgill University Prion protein binding proteins and uses thereof
AU2001232994A1 (en) 2000-01-31 2001-08-07 The Regents Of The University Of California Compositions treated to inactivate infectious proteins
WO2001056456A2 (en) * 2000-02-02 2001-08-09 Cygene, Inc. Methods and compositions for detection of disease
US6387858B1 (en) 2000-03-31 2002-05-14 Steris Inc. Safe transport gel for treating medical instruments
FR2814177B1 (fr) * 2000-09-20 2002-11-22 Univ Grenoble 1 Procede de propagation, in vitro, de l'agent responsable des encephalopathies spongiformes transmissibles, lignees cellulaires obtenues et utilisations
US6696074B2 (en) 2000-12-04 2004-02-24 Tei Biosciences, Inc. Processing fetal or neo-natal tissue to produce a scaffold for tissue engineering
ATE285256T1 (de) 2001-05-11 2005-01-15 Steris Inc Nicht-dispersiver infrarotsensor für verdampftes wasserstoffperoxid
US7001873B2 (en) * 2001-10-05 2006-02-21 Steris Inc. Decontamination of surfaces contaminated with prion-infected material with oxidizing agent-based formulations
CA2812761C (en) * 2001-10-05 2018-03-20 Steris Inc. In vitro model for priocidal activity
US7803315B2 (en) 2001-10-05 2010-09-28 American Sterilizer Company Decontamination of surfaces contaminated with prion-infected material with gaseous oxidizing agents
GB0218314D0 (en) 2002-08-07 2002-09-11 Albagaia Ltd Apparatus and method for treatment of chemical and biological hazards

Also Published As

Publication number Publication date
WO2003031987A3 (en) 2004-02-26
CA2462871C (en) 2013-07-02
EP1432993A2 (en) 2004-06-30
CA2964442C (en) 2018-07-17
JP2005528883A (ja) 2005-09-29
ATE554755T1 (de) 2012-05-15
US20060263821A1 (en) 2006-11-23
CA2462871A1 (en) 2003-04-17
CA2812761A1 (en) 2003-04-17
JP2007277229A (ja) 2007-10-25
AU2002348517B2 (en) 2007-04-26
CN1639575A (zh) 2005-07-13
CA2964442A1 (en) 2003-04-17
EP1432993B1 (en) 2012-04-25
WO2003031987A2 (en) 2003-04-17
BR0213121A (pt) 2006-05-23
US7129080B2 (en) 2006-10-31
US20030148385A1 (en) 2003-08-07
CA2812761C (en) 2018-03-20
ES2387781T3 (es) 2012-10-01

Similar Documents

Publication Publication Date Title
ECSP105739A (es) Anticuerpos de neutralización contra gdf-8
MXPA04003212A (es) Modelo in vitro para actividad priocida.
DK0749317T3 (da) Terapeutiske anvendelser af dimerprodukter af baktericidt/permeabilitetsforøgende protein
NO962088L (no) Preparat for in vivo-produksjon av terapeutiske produkter
DE602004012816D1 (de) Selbstexpandierbarer Stent und Stenteinbringungssystem zur Behandlung von Gefässerkrankungen
DE60108325D1 (de) Pharmazeutische oder diätetische zusammensetzungen aus pilzen und deren verwendung
DE602006015438D1 (de) Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür
DE602004023201D1 (de) Antimikrobielle medizinprodukte
AR046469A1 (es) Un compuesto absorbente que puede estirarse el articulo absorbente que lo comprende y un metodo para fabricar dicho compuesto absorbente
BR0313548A (pt) Produto alimentìcio com base em cereal compreendendo dha e/ou epa
BRPI0504502A (pt) processo para ralar queijo, material de queijo ralado, e, processo para produzir uma composição de queijo
TW200630128A (en) Active ingredient-containing silicone elastomers
ATE148350T1 (de) Chemische verbindungen
PL1663321T3 (pl) Wysokociśnieniowa sterylizacja do końcowego sterylizowania preparatów farmaceutycznych i wyrobów medycznych
FR2866564B1 (fr) Desinfectant antiseptique et produit cosmetique, produit pharmaceutique ou aliment le contenant
ES2169681A1 (es) Metodo de produccion de filmes de quitosan con una alta capacidad de adherencia celular, producto obrenido y aplicaciones.
ECSP003707A (es) Diazepanes
IL141325A0 (en) Tan-1057 derivatives
CY1110043T1 (el) 2-αμινοβενζουλ παραγωγα
DE60230455D1 (de) Natürliche verbindung für die behandlung von diabetes, deren herstellung und verwendung
UA92604C2 (ru) Композиция стансопорфина с физиологической осмотической концентрацией и ее применение
DE60220837D1 (de) Sterilisator und sterilisationsverfahren
ITBO970722A0 (it) Trattamento di reticolazione e sterilizzazione per la produzione di ma nufatti in polietilene ad elevate caratteristiche tribologiche, parti
BR0313186A (pt) Agente redutor de colesterol proveniente de fibra alimentar e substâncias redutoras de colesterol
FR2866234B1 (fr) Desinfectant antiseptique et produit cosmetique, produit pharmaceutique ou aliment le contenant

Legal Events

Date Code Title Description
FG Grant or registration